Evogene receives Nasdaq notice for minimum bid price deficiency

Go back to Evogene receives Nasdaq notice for minimum bid price deficiency

Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification

April 2, 2026 4:01 PM EDT

REHOVOT, Israel, April 2, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN)(TASE: EVGN) (the "Company", "Evogene"), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural... More